In multivariate analyses (including age, gender, resection status, UICC stage, MSI-status, WHO grade, tumour budding, CRC subtypes and SATB2-groups) SATB2-expression was not an independent prognostic factor (e.g., DSS: p = 0.1, hazard ratio: 1.25, Table S5) in the overall cohort comprising all CRCs. The gene discussed is SATB2; the disease is neoplasm.